An Early Warning About GLP-1 Weight Loss Drugs That Was Easy to Dismiss Long before this analysis, concerns were already being raised
10.1038/sj.bjp.0705397 [DOI] [PMC free article] [PubMed] [Google Scholar] 163.Tschen SI, Dhawan S, Gurlo T, Bhushan A
Lyons SK, Hermann JM, Miller KM et al (2017) Use of adjuvant pharmacotherapy in type 1 diabetes: international comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries
GLP-1 receptor agonists have transformed weight management for millions, yet many patients stop treatment early because they don't anticipate side effects
From a methodological standpoint, extrapolating from preclinical to clinical findings necessitates careful interpretation
Staving off potential criticism with a self-deprecating joke